My research focuses on breast cancer biology and translational cancer research, with expertise in cancer biomarkers, microbiome research, proteomics, extracellular vesicles and multi-omics. My work investigates molecular mechanisms underlying breast cancer development, treatment response and therapeutic resistance, integrating clinical samples with laboratory-based and molecular approaches to identify clinically relevant biomarkers and potential therapeutic targets.

A major focus of my research is the identification and validation of molecular and microbial signatures associated with breast cancer subtypes, treatment response, disease progression and patient outcomes. I investigate the interactions between the tumour, host and microbiome using integrated approaches including proteomics, microbiome profiling, extracellular vesicle analysis and other liquid-biopsy strategies.